These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14327527)

  • 1. CHANGES IN THE PHOSPHATE CONTENT OF MYCOBACTERIA PRODUCED BY ISONIAZID AND ETHAMBUTOL.
    YOUATT J
    Aust J Exp Biol Med Sci; 1965 Jun; 43():305-14. PubMed ID: 14327527
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANTITUBERCULOUS ACTIVITY OF DEXTRO-2,2'-(ETHYLENEDIIMINO)-DI-1-BUTANOL (ETHAMBUTOL). (II) COMBINED EFFECT OF ETHAMBUTOL AND ISONIAZID].
    MORIYAMA E
    Kekkaku; 1964 Jun; 39():191-6. PubMed ID: 14173350
    [No Abstract]   [Full Text] [Related]  

  • 3. [EXPERIMENTAL STUDIES ON A NEW ANTITUBERCULAR AGENT DIAMBUTOL].
    BREGER MA; CHERNUKH AM
    Biull Eksp Biol Med; 1963 Oct; 55():55-7. PubMed ID: 14188227
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
    Sener A; Akçalı A; Karatağ O; Koşar S; Değirmenci Y; Akman T
    Mikrobiyol Bul; 2012 Oct; 46(4):689-94. PubMed ID: 23188583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYNTHESIS AND ANTITUBERCULAR ACTIVITY OF ISONICOTINOYL AND CYANOACETYL HYDRAZONES.
    CHAKRAVARTY D; BOSE A; BOSE S
    J Pharm Sci; 1964 Sep; 53():1036-9. PubMed ID: 14234890
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
    Trakada G; Tsiamita M; Spiropoulos K
    Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ANTITUBERCULAR DRUGS. XIV. ISONICOTINOYLHYDRAZONES OF SOME PHENYLGLYOXYLIC ACIDS].
    BUDESINSKY Z; BYDZOVSKY V; SLUKA J
    Cesk Farm; 1964 Sep; 13():345-9. PubMed ID: 14196184
    [No Abstract]   [Full Text] [Related]  

  • 9. THE ACCUMULATION OF FREE TREHALOSE BY MYCOBACTERIA EXPOSED TO ISONIAZID.
    WINDER F; BRENNAN P
    Biochim Biophys Acta; 1964 Aug; 90():442-4. PubMed ID: 14220743
    [No Abstract]   [Full Text] [Related]  

  • 10. [ANTIMYCOBACTERIAL ACTIVITY OF ISOXYL. II. EXPERIMENTS WITH GUINEA PIGS AND RABBITS].
    URBANCIK R; TRNKA L; KRUML J; POLENSKA H
    Pathol Microbiol (Basel); 1964; 27():79-87. PubMed ID: 14107358
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
    Lounis N; Maslo C; Truffot-Pernot C; Grosset J; Boelaert RJ
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):575-9. PubMed ID: 12797701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of antitubercular agents on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):227-31. PubMed ID: 4973007
    [No Abstract]   [Full Text] [Related]  

  • 14. ACTIVITY OF ANTITUBERCULOSIS DRUGS AGAINST MYCOBACTERIUM LEPRAE.
    SHEPARD CC; CHANG YT
    Int J Lepr; 1964; 32():260-71. PubMed ID: 14227399
    [No Abstract]   [Full Text] [Related]  

  • 15. [ACTION OF IONIZING RADIATIONS ON MYCOBACTERIA].
    DELLESEDIE PF; NASSI N; SBRAGIA S
    Nuovi Ann Ig Microbiol; 1964; 15():56-68. PubMed ID: 14185127
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv.
    Jia L; Coward L; Gorman GS; Noker PE; Tomaszewski JE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):905-11. PubMed ID: 16085758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EFFECT OF ETHAMBUTOL ON CYTOLOGY OF MYCOBACTERIUM SMEGMATIS.
    GALE GR; MCLAIN HH
    J Bacteriol; 1963 Oct; 86(4):749-56. PubMed ID: 14066471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meta analysis on the correlation between Mycobacterium tuberculosis Beijing family strains and drug resistance].
    Liu BB; Lu LP; Lü B; Wan KL; Yan Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Feb; 46(2):158-64. PubMed ID: 22490200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.